Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
44,529,426
-
Share change
-
-297,038
-
Total reported value
-
$1,939,376,023
-
Put/Call ratio
-
14%
-
Price per share
-
$43.55
-
Number of holders
-
158
-
Value change
-
-$30,688,010
-
Number of buys
-
70
-
Number of sells
-
84
Institutional Holders of ACCELERON PHARMA INC - COMMON STOCK (XLRN) as of Q4 2018
As of 31 Dec 2018,
ACCELERON PHARMA INC - COMMON STOCK (XLRN) was held by
158 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,529,426 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., Vanguard Group Inc, FARALLON CAPITAL MANAGEMENT LLC, STATE STREET CORP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), WESTFIELD CAPITAL MANAGEMENT CO LP, JANUS HENDERSON GROUP PLC, and Artal Group S.A..
This page lists
158
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.